StreetInsider.com News Articles http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 17 Jun 2026 21:22:06 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech prices $226 million public offering of ADS shares http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html <p>Legend Biotech Corporation (NASDAQ: LEGN) has priced an underwritten public offering of 7,700,000 American Depositary Shares (ADSs) at $29.35 per ADS, according to a press release issued June 17, 2026.</p> <p>Each ADS represents two ordinary shares of the Bridgewater, N.J.-based company. The gross proceeds from the offering are expected to be approximately $226 million before deducting underwriting discounts, commissions, and other offering expenses.</p> <p>Legend Biotech has also granted underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. Proceeds from any exercise of that option are not included in the http://www.streetinsider.com/Equity+Offerings/Legend+Biotech+prices+%24226+million+public+offering+of+ADS+shares/26661632.html Wed, 17 Jun 2026 21:22:06 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech Corporation Announces Pricing of Public Offering http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html <p align="left">BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html Wed, 17 Jun 2026 21:21:00 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech Corporation Announces Pricing of Public Offering http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html <p align="left">BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html Wed, 17 Jun 2026 21:21:00 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech Corporation Announces Pricing of Public Offering http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html <p align="left">BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html Wed, 17 Jun 2026 21:21:00 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech Corporation Announces Pricing of Public Offering http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html <p align="left">BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html Wed, 17 Jun 2026 21:21:00 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech Corporation Announces Pricing of Public Offering http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html <p align="left">BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html Wed, 17 Jun 2026 21:21:00 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech Corporation Announces Pricing of Public Offering http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html <p align="left">BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html Wed, 17 Jun 2026 21:21:00 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech Corporation Announces Pricing of Public Offering http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html <p align="left">BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html Wed, 17 Jun 2026 21:21:00 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech Corporation Announces Pricing of Public Offering http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html <p align="left">BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html Wed, 17 Jun 2026 21:21:00 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech Corporation Announces Pricing of Public Offering http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html <p align="left">BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html Wed, 17 Jun 2026 21:21:00 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech Corporation Announces Pricing of Public Offering http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html <p align="left">BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html Wed, 17 Jun 2026 21:21:00 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech Corporation Announces Pricing of Public Offering http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html <p align="left">BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html Wed, 17 Jun 2026 21:21:00 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870 Legend Biotech Corporation Announces Pricing of Public Offering http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html <p align="left">BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross http://www.streetinsider.com/Press+Releases/Legend+Biotech+Corporation+Announces+Pricing+of+Public+Offering/26661631.html Wed, 17 Jun 2026 21:21:00 -0400 A.00698355 A.15776824 A.33831941 A.36626790 A.50213493 LEGN O.00985197 O.14919071 O.26391695 O.47551171 O.47731837 O.51342512 O.60764870